The Supreme Court on May 4 temporarily reinstated access to the abortion drug mifepristone by mail, pausing an appeals court ruling that had banned remote prescriptions while the FDA conducts a regulatory review. Justice Samuel Alito's order allows telehealth providers to dispense the medication until at least May 11, following emergency requests from mifepristone manufacturers.
At the request of drugmakers, Justice Samuel Alito paused until May 11 the restrictive ruling by a lower court while the full court decides what the rules for mifepristone should be as Louisiana challenges expanded access.
Turn out it wasn't even to benefit the public, it's because a drug company lobbied them.
4 comments
The Supreme Court on May 4 temporarily reinstated access to the abortion drug mifepristone by mail, pausing an appeals court ruling that had banned remote prescriptions while the FDA conducts a regulatory review. Justice Samuel Alito's order allows telehealth providers to dispense the medication until at least May 11, following emergency requests from mifepristone manufacturers.
To paraphrase the old saying, even a broken clock is right twice a day.
But beware that the other foot hasn't yet dropped.
Turn out it wasn't even to benefit the public, it's because a drug company lobbied them.
I couldn't imagine Alito doing the right thing under any other circumstances.